We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.41B
AUM Growth
+$279M
Cap. Flow
+$377M
Cap. Flow %
26.74%
Top 10 Hldgs %
7.59%
Holding
877
New
177
Increased
293
Reduced
202
Closed
151

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$7.53M
2
FRPT icon
Freshpet
FRPT
+$6.94M
3
S icon
SentinelOne
S
+$6.3M
4
ANET icon
Arista Networks
ANET
+$6.03M
5
CVNA icon
Carvana
CVNA
+$5.95M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$6.92M
2
F icon
Ford
F
+$6.05M
3
BIIB icon
Biogen
BIIB
+$6.03M
4
AKRO
Akero Therapeutics
AKRO
+$5.18M
5
RL icon
Ralph Lauren
RL
+$4.73M

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 19.71%
3 Consumer Discretionary 12.99%
4 Industrials 11.27%
5 Financials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWAN
126
DELISTED
Clearwater Analytics
CWAN
$3.54M 0.25%
131,970
+29,108
+28% +$817K
SKWD icon
127
Skyward Specialty Insurance
SKWD
$2.54B
$3.51M 0.25%
66,371
+9,969
+18% +$480K
TSN icon
128
Tyson Foods
TSN
$21.5B
$3.51M 0.25%
54,936
+13,657
+33% +$802K
HAE icon
129
Haemonetics
HAE
$3.75B
$3.5M 0.25%
55,101
+44,933
+442% +$3.06M
ESE icon
130
ESCO Technologies
ESE
$8.18B
$3.48M 0.25%
21,874
SAIC icon
131
Saic
SAIC
$5.14B
$3.44M 0.24%
+30,649
New +$3.31M
SRPT icon
132
Sarepta Therapeutics
SRPT
$1.63B
$3.43M 0.24%
53,781
+38,033
+242% +$4M
CHTR icon
133
Charter Communications
CHTR
$16.7B
$3.39M 0.24%
+9,201
New +$3.29M
VERX icon
134
Vertex
VERX
$2.14B
$3.38M 0.24%
96,465
+69,565
+259% +$3.18M
TOST icon
135
Toast
TOST
$18.8B
$3.37M 0.24%
101,556
-13,569
-12% -$508K
VRN
136
DELISTED
Veren
VRN
$3.36M 0.24%
508,248
-121,904
-19% -$675K
ITRI icon
137
Itron
ITRI
$4.75B
$3.32M 0.24%
31,675
-9,119
-22% -$955K
STNE icon
138
StoneCo
STNE
$2.71B
$3.31M 0.23%
+315,438
New +$2.97M
LBTYK icon
139
Liberty Global Class C
LBTYK
$3.4B
$3.29M 0.23%
274,895
+241,595
+726% +$2.91M
BLBD icon
140
Blue Bird Corp
BLBD
$2.34B
$3.29M 0.23%
101,488
+41,704
+70% +$1.53M
NTLA icon
141
Intellia Therapeutics
NTLA
$1.52B
$3.27M 0.23%
460,246
+132,638
+40% +$1.34M
APH icon
142
Amphenol
APH
$177B
$3.26M 0.23%
49,719
+35,319
+245% +$2.41M
MTDR icon
143
Matador Resources
MTDR
$5.73B
$3.24M 0.23%
63,350
+27,582
+77% +$1.52M
FRSH icon
144
Freshworks
FRSH
$3.09B
$3.23M 0.23%
229,060
+194,034
+554% +$3.25M
BMBL icon
145
Bumble
BMBL
$393M
$3.23M 0.23%
743,743
+526,629
+243% +$3.43M
PANW icon
146
Palo Alto Networks
PANW
$260B
$3.21M 0.23%
+18,800
New +$3.48M
SYNA icon
147
Synaptics
SYNA
$4.33B
$3.19M 0.23%
50,030
+22,980
+85% +$1.67M
PNC icon
148
PNC Financial Services
PNC
$100B
$3.18M 0.23%
18,094
-6,909
-28% -$1.3M
PNR icon
149
Pentair
PNR
$10.8B
$3.18M 0.23%
36,349
ALAB icon
150
Astera Labs
ALAB
$44.6B
$3.17M 0.23%
53,157
+28,121
+112% +$2.6M

Similar funds

PDT Partners's Q1 2025 Portfolio in Review

As of Q1 2025, PDT Partners held 877 positions worth $1.41B, up 25% from $1.13B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

PDT Partners deployed $377M of net new capital in Q1 2025, opening 177 new positions and adding to 293 existing holdings. Its largest new stake was Target: 44,300 shares worth $4.62M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Robinhood, an estimated $6.92M trimmed.

  • PDT Partners's largest Q1 2025 buy was Target: 44,300 shares worth $4.62M.
  • PDT Partners added most to Moderna in Q1 2025, an estimated $7.53M increase.
  • PDT Partners's biggest Q1 2025 reduction was Robinhood, cutting an estimated $6.92M.
  • PDT Partners fully exited Biogen in Q1 2025, selling an estimated $6.03M.
  • PDT Partners's ten largest holdings make up 7.6% of its $1.41B portfolio in Q1 2025.
  • PDT Partners opened 177 new positions and closed 151 in Q1 2025.
  • PDT Partners's portfolio value rose 25% quarter-over-quarter to $1.41B.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.